anaveon
  • About
    • Our Journey
    • About Us
    • Anaveon In Depth
  • Science
    • Our Approach
    • Publications
  • Team
    • Our Team
    • Our Board
    • Our Investors
  • News
  • Career
  • Contact Us
Select Page
HomeNovember
Anaveon announces poster presentation at the 2021 Society for Immunotherapy of Cancer Annual Meeting

Anaveon announces poster presentation at the 2021 Society for Immunotherapy of Cancer Annual Meeting

by admin | Nov 12, 2021 | Press Releases

Anaveon, a clinical stage, immuno-oncology company, today announced that it will present a poster on its lead program ANV419 at the Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting being held from Wednesday, November 10, 2021 to Sunday, November 14, 2021.

Search here

Categories

  • Press Releases 17

Recent Posts

  • Anaveon appoints Dr Eduard Gasal as Chief Medical Officer
    November 30, 2022
  • Anaveon presents updated data from the Phase I/II study of ANV419 during the SITC Annual Meeting
    November 10, 2022
  • Anaveon announces upcoming poster presentations at the 37th Society for Immunotherapy of Cancer Annual Meeting
    October 31, 2022

We are social

Popular Tags

#ANV419 #ESMO22 #phaseI/II 2020 AACR Annual Meeting anaveon brand clinical data CTA approval First patient investment news phase I phase I/II study phase II presentation press solid tumors start trial study data team website

Archives

  • November 2022  2
  • October 2022  1
  • September 2022  1
  • July 2022  3
  • April 2022  1
  • March 2022  1
  • December 2021  1
  • November 2021  1
  • June 2021  1
  • March 2021  1
  • November 2020  1
  • May 2020  1
  • April 2019  1
  • February 2019  1
Anaveon_ submark

Contact us

Email

contact@anaveon.com

Postal Address

Anaveon AG

Technologiepark Basel

Hochbergerstrasse 60C

4057 Basel

Switzerland

Follow us

  • Linkedin
  • Home
  • Privacy Policy
  • Photography Credit

© 2020 All Rights Reserved